Hypergonadotropic hypogonadism-cataract syndrome

Hypergonadotropic hypogonadism-cataract syndrome, also known as Lubinsky syndrome, is an extremely rare genetic condition characterized by the combination of hypergonadotropic hypogonadism and cataracts. Hypergonadotropic hypogonadism refers to a condition in which the gonads (testes in males) fail to function properly despite elevated levels of gonadotropins (LH and FSH) — the pituitary hormones that normally stimulate the gonads. This results in impaired sex hormone production and can lead to delayed or incomplete puberty, infertility, and underdevelopment of secondary sexual characteristics. The ICD-10 code E29.1 reflects testicular hypofunction in affected males. In addition to gonadal dysfunction, affected individuals develop cataracts (clouding of the lens of the eye), which can impair vision. The syndrome primarily affects the endocrine/reproductive system and the eyes. Only a very small number of cases have been described in the medical literature, making it one of the rarest recognized genetic syndromes. Additional features reported in some patients may include intellectual disability and other variable findings, though the core features remain hypergonadotropic hypogonadism and bilateral cataracts. Treatment is symptomatic and supportive: hormone replacement therapy (such as testosterone in males) can address the hypogonadism and promote development of secondary sexual characteristics, while cataract surgery may be performed to restore or preserve vision. Genetic counseling is recommended for affected families. There is currently no cure or disease-specific therapy available for this condition.

Common questions about Hypergonadotropic hypogonadism-cataract syndrome